BACKGROUND: Epithelial-to-mesenchymal transition (EMT) of peritoneal mesothelial cells has been regarded as an early mechanism of peritoneal fibrosis. A substantial and rapidly growing literature indicates that HO-1 provides the provenance for pathways that can interrupt virtually all major mechanisms of tissue injury. The effects of HO-1 expression on EMT, which plays a critical role in the development of peritoneal membrane (PM) fibrosis, are unknown and its roles in peritoneal fibrosis has not been studied, yet. METHODS: A piece of human omentum obtained from consenting patients undergoing elective abdominal surgery was used for study. We treated the human peritoneal mesothelial cells (HPMCs) with high glucose solution and HO-1 inducer (hemin, 10 μmol/L). To further investigate the pure effect of HO-1 on EMT of mesothelium, gene transfer of recombinant Adenovirus-harboring human HO-1 (Adv-HO-1 gene) to HPMCs was done. RESULTS: Exposure of HPMCs to HG solution resulted in an increase of the expression of mesenchymal markers such as α-smooth muscle actin (α-SMA) and was associated with a decrease in the expression of epithelial markers, E-cadherin. HO-1 protein expression was decreased in the same situation. Treatment of HPMCs with HO-1 inducer, hemin showed a dosage-dependent amelioration of HG induced changes in markers of EMT with increase of expression of HO-1. Human HO-1 gene transfection resulted in a significant increase in HO-1 expression and ameliorated HG-induced changes in expression of E-cadherin and α-SMA. CONCLUSION: Taken together, our results suggest that HO-1 has a critical role in the modulation of peritoneal fibrosis, and, more important, the suppression of EMT. This study is the first to show the beneficial effect of HO-1 on reversing EMT in MC.
BACKGROUND: Epithelial-to-mesenchymal transition (EMT) of peritoneal mesothelial cells has been regarded as an early mechanism of peritoneal fibrosis. A substantial and rapidly growing literature indicates that HO-1 provides the provenance for pathways that can interrupt virtually all major mechanisms of tissue injury. The effects of HO-1 expression on EMT, which plays a critical role in the development of peritoneal membrane (PM) fibrosis, are unknown and its roles in peritoneal fibrosis has not been studied, yet. METHODS: A piece of human omentum obtained from consenting patients undergoing elective abdominal surgery was used for study. We treated the human peritoneal mesothelial cells (HPMCs) with high glucose solution and HO-1 inducer (hemin, 10 μmol/L). To further investigate the pure effect of HO-1 on EMT of mesothelium, gene transfer of recombinant Adenovirus-harboring humanHO-1 (Adv-HO-1 gene) to HPMCs was done. RESULTS: Exposure of HPMCs to HG solution resulted in an increase of the expression of mesenchymal markers such as α-smooth muscle actin (α-SMA) and was associated with a decrease in the expression of epithelial markers, E-cadherin. HO-1 protein expression was decreased in the same situation. Treatment of HPMCs with HO-1 inducer, hemin showed a dosage-dependent amelioration of HG induced changes in markers of EMT with increase of expression of HO-1. HumanHO-1 gene transfection resulted in a significant increase in HO-1 expression and ameliorated HG-induced changes in expression of E-cadherin and α-SMA. CONCLUSION: Taken together, our results suggest that HO-1 has a critical role in the modulation of peritoneal fibrosis, and, more important, the suppression of EMT. This study is the first to show the beneficial effect of HO-1 on reversing EMT in MC.
Authors: Luiz S Aroeira; Abelardo Aguilera; Rafael Selgas; Marta Ramírez-Huesca; M Luisa Pérez-Lozano; Antonio Cirugeda; M Auxiliadora Bajo; Gloria del Peso; José A Sánchez-Tomero; José A Jiménez-Heffernan; Manuel López-Cabrera Journal: Am J Kidney Dis Date: 2005-11 Impact factor: 8.860
Authors: Jesús Loureiro; Margot Schilte; Abelardo Aguilera; Patricia Albar-Vizcaíno; Marta Ramírez-Huesca; M Luisa Pérez-Lozano; Guadalupe González-Mateo; Luiz S Aroeira; Rafael Selgas; Lorea Mendoza; Alberto Ortiz; Marta Ruíz-Ortega; Jacob van den Born; Robert H J Beelen; Manuel López-Cabrera Journal: Nephrol Dial Transplant Date: 2010-01-12 Impact factor: 5.992
Authors: G Del Peso; J A Jiménez-Heffernan; M A Bajo; L S Aroeira; A Aguilera; A Fernández-Perpén; A Cirugeda; M J Castro; R de Gracia; R Sánchez-Villanueva; J A Sánchez-Tomero; M López-Cabrera; R Selgas Journal: Kidney Int Suppl Date: 2008-04 Impact factor: 10.545
Authors: Xiao-ming Liu; Kelly J Peyton; Diana Ensenat; Hong Wang; Andrew I Schafer; Jawed Alam; William Durante Journal: J Biol Chem Date: 2004-11-16 Impact factor: 5.157